Behind the Bell: Guardant Health

Published

About this Series

Behind the Bell

Behind the Bell is an interview series featuring CEOs, executives or founders, live from MarketSite on a company’s listing day or milestone celebration—generally in the moments after ringing the opening or closing bell.

In this episode of Behind the Bell, Guardant Health joined us at MarketSite to ring the opening bell to celebrate receiving FDA approval for their blood test that screens for colorectal cancer. Co-Founder & Co-CEO AmirAli Talasaz chatted with us about how the company is working to create a healthier future for all.

Nasdaq Watch

See what's playing at Nasdaq

Watch Now